Signal active
Organization
Contact Information
Overview
AutoPhagyGO offers autophagy solutions for the prevention and treatment of neurodegenerative diseases. Autophagy, the primary mechanism that controls lifespan, is controlled by its numerous aging-related occurrences and diseases may be preventable and treatable. The company uses the findings of the most recent autophagy research to promote healthy longevity.
About
Biotechnology, Health Care, Medical, Health Diagnostics
2019
1-10
Headquarters locations
Asia
Social
N/A
Profile Resume
AutoPhagyGO headquartered in Asia, operates in the Biotechnology, Health Care, Medical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $29.7M in funding across 32 round(s). With a team of 1-10 employees, AutoPhagyGO is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - AutoPhagyGO, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
2
1
0
$928.4K
Details
1
AutoPhagyGO has raised a total of $928.4K in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | 928.4K |
Investors
AutoPhagyGO is funded by 6 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
AutoPhagyGO | - | FUNDING ROUND - AutoPhagyGO | 928.4K |
UHA Mikakuto | - | FUNDING ROUND - UHA Mikakuto | 928.4K |
AutoPhagyGO | - | FUNDING ROUND - AutoPhagyGO | undefined |
Healthcare Innovation | - | FUNDING ROUND - Healthcare Innovation | undefined |
Recent Activity
There is no recent news or activity for this profile.